NMB

2,7-DIBENZYL-1,1-DIOXO-3,6-BIS-PHENOXYMETHYL-[1,2,7]THIADIAZEPANE-4,5-DIOL

Created:	1999-07-08
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where NMB is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	75
Chiral Atom Count	4
Bond Count	79
Aromatic Bond Count	24

2D diagram of NMB

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2,7-DIBENZYL-1,1-DIOXO-3,6-BIS-PHENOXYMETHYL-[1,2,7]THIADIAZEPANE-4,5-DIOL
Systematic Name (OpenEye OEToolkits)	(2R,3R,4S,5S,6R,7R)-1,1-dioxo-3,6-bis(phenoxymethyl)-2,7-bis(phenylmethyl)-1,2,7-thiadiazepane-4,5-diol
Formula	C₃₂ H₃₄ N₂ O₆ S
Molecular Weight	574.687
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	O=S2(=O)N(C(C(O)C(O)C(N2Cc1ccccc1)COc3ccccc3)COc4ccccc4)Cc5ccccc5
SMILES	CACTVS	3.341	O[CH]1[CH](O)[CH](COc2ccccc2)N(Cc3ccccc3)[S](=O)(=O)N(Cc4ccccc4)[CH]1COc5ccccc5
SMILES	OpenEye OEToolkits	1.5.0	c1ccc(cc1)CN2C(C(C(C(N(S2(=O)=O)Cc3ccccc3)COc4ccccc4)O)O)COc5ccccc5
Canonical SMILES	CACTVS	3.341	O[C@@H]1[C@@H](O)[C@@H](COc2ccccc2)N(Cc3ccccc3)[S](=O)(=O)N(Cc4ccccc4)[C@@H]1COc5ccccc5
Canonical SMILES	OpenEye OEToolkits	1.5.0	c1ccc(cc1)C[N@@]2[C@@H]([C@@H]([C@H]([C@H]([N@](S2(=O)=O)Cc3ccccc3)COc4ccccc4)O)O)COc5ccccc5
InChI	InChI	1.03	InChI=1S/C32H34N2O6S/c35-31-29(23-39-27-17-9-3-10-18-27)33(21-25-13-5-1-6-14-25)41(37,38)34(22-26-15-7-2-8-16-26)30(32(31)36)24-40-28-19-11-4-12-20-28/h1-20,29-32,35-36H,21-24H2/t29-,30-,31+,32+/m1/s1
InChIKey	InChI	1.03	CAGHBXQSDLNCES-ZRTHHSRSSA-N

Related Resource References

Resource Name	Reference
PubChem	444289
ChEMBL	CHEMBL130998

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.